Clarification needed regarding use of bismuth salicylate.
Eenigenburg
David L
DL
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects; D000930:Antidiarrheals / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D003967:Diarrhea / Q000188:drug therapy* / Q000517:prevention & control*; D004334:Drug Administration Schedule; D054796:Drug Dosage Calculations; D062787:Drug Overdose / Q000517:prevention & control; D006801:Humans; D010506:Periodicals as Topic; D017410:Practice Guidelines as Topic; D012202:Reye Syndrome / Q000139:chemically induced / Q000517:prevention & control; D012306:Risk; D012459:Salicylates / Q000008:administration & dosage* / Q000009:adverse effects; D014195:Travel
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000930:Antidiarrheals; D012459:Salicylates; C496893:Bismuth Salicylate